Search research articles
Contact Us
Filters
Showing results (141-150 of 319) with videos related to
Page
of 32
Sort By:
Bioconjugate Chemistry
|
October 10, 2007
Preparation and evaluation of glycosylated arginine-glycine-aspartate (RGD) derivatives for integrin targeting
Brian H M Kuijpers, Stan Groothuys, Annemieke C Soede, et al.
Tissue Engineering. Part C, Methods
|
December 25, 2012
Dual contrast agent for computed tomography and magnetic resonance hard tissue imaging
Manuela Ventura, Yi Sun, Viorel Rusu, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
December 21, 2010
Renal uptake of different radiolabelled peptides is mediated by megalin: SPECT and biodistribution studies in megalin-deficient mice
Erik Vegt, Marleen Melis, Annemarie Eek, et al.
Bioconjugate Chemistry
|
May 20, 2004
Two technetium-99m-labeled cholecystokinin-8 (CCK8) peptides for scintigraphic imaging of CCK receptors
Peter Laverman, Martin Béhé, Wim J G Oyen, et al.
International Journal of Cancer
|
November 11, 2006
Alpha v beta 3 integrin-targeting of intraperitoneally growing tumors with a radiolabeled RGD peptide
Ingrid Dijkgraaf, John A W Kruijtzer, Cathelijne Frielink, et al.
Bioconjugate Chemistry
|
March 22, 2002
Effects of coligand variation on the in vivo characteristics of Tc-99m-labeled interleukin-8 in detection of infection
Huub J J M Rennen, Julliëtte E van Eerd, Wim J G Oyen, et al.
European Heart Journal
|
December 22, 2009
Rosiglitazone reduces ischaemia-reperfusion injury in patients with the metabolic syndrome
Alexander J Rennings, Patrick Meijer, Dominique J van Uden, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 5, 2002
99mTc-HMPAO-labeled autologous versus heterologous leukocytes for imaging infection
Stefan Gratz, Huub J J M Rennen, Otto C Boerman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 13, 2004
Optimization of radioimmunotherapy of renal cell carcinoma: labeling of monoclonal antibody cG250 with 131I, 90Y, 177Lu, or 186Re
Adrienne H Brouwers, Julliëtte E M van Eerd, Cathelijne Frielink, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 21, 2010
Nephrotoxicity in mice after repeated imaging using 111In-labeled peptides
Marleen Melis, Erik Vegt, Mark W Konijnenberg, et al.
Page
of 32
Search research articles
Search
Showing results (141-150 of 319) with videos related to
Sort By:
Page
of 32
Bioconjugate Chemistry
|
October 10, 2007
Preparation and evaluation of glycosylated arginine-glycine-aspartate (RGD) derivatives for integrin targeting
Brian H M Kuijpers, Stan Groothuys, Annemieke C Soede, et al.
Tissue Engineering. Part C, Methods
|
December 25, 2012
Dual contrast agent for computed tomography and magnetic resonance hard tissue imaging
Manuela Ventura, Yi Sun, Viorel Rusu, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
December 21, 2010
Renal uptake of different radiolabelled peptides is mediated by megalin: SPECT and biodistribution studies in megalin-deficient mice
Erik Vegt, Marleen Melis, Annemarie Eek, et al.
Bioconjugate Chemistry
|
May 20, 2004
Two technetium-99m-labeled cholecystokinin-8 (CCK8) peptides for scintigraphic imaging of CCK receptors
Peter Laverman, Martin Béhé, Wim J G Oyen, et al.
International Journal of Cancer
|
November 11, 2006
Alpha v beta 3 integrin-targeting of intraperitoneally growing tumors with a radiolabeled RGD peptide
Ingrid Dijkgraaf, John A W Kruijtzer, Cathelijne Frielink, et al.
Bioconjugate Chemistry
|
March 22, 2002
Effects of coligand variation on the in vivo characteristics of Tc-99m-labeled interleukin-8 in detection of infection
Huub J J M Rennen, Julliëtte E van Eerd, Wim J G Oyen, et al.
European Heart Journal
|
December 22, 2009
Rosiglitazone reduces ischaemia-reperfusion injury in patients with the metabolic syndrome
Alexander J Rennings, Patrick Meijer, Dominique J van Uden, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 5, 2002
99mTc-HMPAO-labeled autologous versus heterologous leukocytes for imaging infection
Stefan Gratz, Huub J J M Rennen, Otto C Boerman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 13, 2004
Optimization of radioimmunotherapy of renal cell carcinoma: labeling of monoclonal antibody cG250 with 131I, 90Y, 177Lu, or 186Re
Adrienne H Brouwers, Julliëtte E M van Eerd, Cathelijne Frielink, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 21, 2010
Nephrotoxicity in mice after repeated imaging using 111In-labeled peptides
Marleen Melis, Erik Vegt, Mark W Konijnenberg, et al.
Page
of 32